These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 16239547

  • 1. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.
    van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ.
    Infect Immun; 2005 Nov; 73(11):7458-64. PubMed ID: 16239547
    [Abstract] [Full Text] [Related]

  • 2. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction.
    Netea MG, Warris A, Van der Meer JW, Fenton MJ, Verver-Janssen TJ, Jacobs LE, Andresen T, Verweij PE, Kullberg BJ.
    J Infect Dis; 2003 Jul 15; 188(2):320-6. PubMed ID: 12854089
    [Abstract] [Full Text] [Related]

  • 3. Both viable and killed Candida albicans cells induce in vitro production of TNF-alpha and IFN-gamma in murine cells through a TLR2-dependent signalling.
    Murciano C, Yáñez A, Gil ML, Gozalbo D.
    Eur Cytokine Netw; 2007 Mar 15; 18(1):38-43. PubMed ID: 17400537
    [Abstract] [Full Text] [Related]

  • 4. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
    Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ.
    J Infect Dis; 2002 May 15; 185(10):1483-9. PubMed ID: 11992285
    [Abstract] [Full Text] [Related]

  • 5. Induction of nuclear factor- kappa B and c-Jun/activator protein-1 via toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans.
    Roeder A, Kirschning CJ, Schaller M, Weindl G, Wagner H, Korting HC, Rupec RA.
    J Infect Dis; 2004 Oct 01; 190(7):1318-26. PubMed ID: 15346344
    [Abstract] [Full Text] [Related]

  • 6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.
    Int Immunol; 2007 Mar 01; 19(3):311-20. PubMed ID: 17289654
    [Abstract] [Full Text] [Related]

  • 7. Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases.
    Overland G, Stuestøl JF, Dahle MK, Myhre AE, Netea MG, Verweij P, Yndestad A, Aukrust P, Kullberg BJ, Warris A, Wang JE, Aasen AO.
    Scand J Immunol; 2005 Aug 01; 62(2):148-54. PubMed ID: 16101821
    [Abstract] [Full Text] [Related]

  • 8. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L, Dolganiuc A, Kodys K, Drechsler Y, Oak S, Velayudham A, Mandrekar P, Szabo G.
    Hepatology; 2004 Sep 01; 40(3):555-64. PubMed ID: 15349893
    [Abstract] [Full Text] [Related]

  • 9. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, Golenbock D, Kurt-Jones E, Szabo G.
    J Leukoc Biol; 2005 Dec 01; 78(6):1255-64. PubMed ID: 16204620
    [Abstract] [Full Text] [Related]

  • 10. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF.
    J Allergy Clin Immunol; 2006 Sep 01; 118(3):641-8. PubMed ID: 16950283
    [Abstract] [Full Text] [Related]

  • 11. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK.
    Immunol Lett; 2009 Apr 27; 123(2):138-43. PubMed ID: 19428561
    [Abstract] [Full Text] [Related]

  • 12. TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans.
    Chassin C, Picardeau M, Goujon JM, Bourhy P, Quellard N, Darche S, Badell E, d'Andon MF, Winter N, Lacroix-Lamandé S, Buzoni-Gatel D, Vandewalle A, Werts C.
    J Immunol; 2009 Aug 15; 183(4):2669-77. PubMed ID: 19635914
    [Abstract] [Full Text] [Related]

  • 13. Melanocytes and melanin represent a first line of innate immunity against Candida albicans.
    Tapia CV, Falconer M, Tempio F, Falcón F, López M, Fuentes M, Alburquenque C, Amaro J, Bucarey SA, Di Nardo A.
    Med Mycol; 2014 Jul 15; 52(5):445-54. PubMed ID: 24934806
    [Abstract] [Full Text] [Related]

  • 14. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.
    Van der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van der Meer JW, Kullberg BJ.
    Eur Cytokine Netw; 2006 Mar 15; 17(1):29-34. PubMed ID: 16613760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis.
    van der Graaf CA, Netea MG, Drenth IP, te Morsche RH, van der Meer JW, Kullberg BJ.
    Neth J Med; 2003 Nov 15; 61(11):365-9. PubMed ID: 14768719
    [Abstract] [Full Text] [Related]

  • 18. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells.
    Covacu R, Arvidsson L, Andersson A, Khademi M, Erlandsson-Harris H, Harris RA, Svensson MA, Olsson T, Brundin L.
    J Immunol; 2009 Jun 01; 182(11):6889-95. PubMed ID: 19454685
    [Abstract] [Full Text] [Related]

  • 19. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.
    Villamón E, Gozalbo D, Roig P, Murciano C, O'Connor JE, Fradelizi D, Gil ML.
    Eur Cytokine Netw; 2004 Jun 01; 15(3):263-71. PubMed ID: 15542452
    [Abstract] [Full Text] [Related]

  • 20. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
    Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y.
    Mol Pharmacol; 2006 Apr 01; 69(4):1288-95. PubMed ID: 16373689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.